A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...

Synovitis is significantly more likely among patients with psoriasis, and it is more likely among those with PsA than PsO.